A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
Clinical trial NCT07352969 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07352969
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-06
- Primary completion
- 2029-03-27
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.